12,000 square meters for research: pharmaceutical company Pieris Pharmaceuticals GmbH comes to Hallbergmoos

Munich Airport Business Park is getting a new addition: the German branch of US pharmaceutical company Pieris Pharmaceuticals Inc. is moving into Skygate. The specialist for respiratory diseases and immuno-oncology will move into its new premises in 2019, covering around 12,000 square meters.

Munich Airport Business Park has landed a big fish: The pharmaceutical company Pieris Pharmaceuticals GmbH will move into approximately 12,000 square meters in Hallbergmoos step-by-step in 2019. A state-of-the-art laboratory environment for research and development will be at the heart of the new site, and the expansion of the Germany-wide team will also be on the agenda.

Pieris Pharmaceuticals GmbH is a subsidiary of the American – Nasdaq-listed – pharmaceutical group Pieris Pharmaceuticals Inc. The company’s German headquarters are currently still located in Freising-Weihenstephan. Pieris Pharmaceuticals Inc. was founded by the Munich Professor of Biological Chemistry Prof. Dr. Arne Skerra. He and his research team succeeded in developing anticalins, artificially produced proteins capable of binding antigens. Pieris Pharmaceuticals GmbH conducts research into anticalin engineering in order to develop them as drug carriers in the fields of immuno-oncology, respiratory diseases and anemia.

Pieris Pharmaceuticals GmbH will move into the Munich Aiport Business Park from 2019, with the first phase of the move taking place at the end of 2019 on around 10,000 square meters and the remaining 2,000 square meters at a later date. “We are delighted to have gained Pieris Pharmaceuticals as a tenant,” says Alexander Mademann from the Hallbergmoos municipality’s business development department. “It perfectly complements the diversity of industries in the MABP.”

With the major letting to Pieris Pharmaceuticals GmbH, Skygate has reached an occupancy rate of around 85%. The MABP would also like to attract further tenants from the pharmaceutical industry to the business park in the future: “In the future, we want to give the pharmaceutical industry a greater weighting at the location and look for further tenants,” says Mademann. International companies should also increasingly find their way to the business park in the future.

Image material © Gemeinde Hallbergmoos/ Rock Capital Group/ Pieris

This is where you check in!

Newsroom

Further contributions